<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03653715</url>
  </required_header>
  <id_info>
    <org_study_id>CVR-18-001</org_study_id>
    <nct_id>NCT03653715</nct_id>
  </id_info>
  <brief_title>Bifocal Contact Lens Study for Adults With Age-Related Near Vision Loss</brief_title>
  <official_title>Clinical Performance Study of Clerio Single Vision and Bifocal Contact Lens Designs Immediately Following Insertion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clerio Vision, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clerio Vision, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to evaluate the distance, intermediate and near visual
      performance of Clerio designed single vision and Clerio designed LIRIC modified bifocal
      lenses (+2.00D add) compared to commercially available single vision and multifocal lenses.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clerio Vision Inc. has licensed a new femtosecond based laser procedure discovered by
      researchers at the University of Rochester known as Laser Induced Refractive Index
      Customization (LIRIC), which allows the alteration of the optical design of a finished soft
      hydrogel contact lens. Clerio Vision Inc. scientists have developed a diffractive multifocal
      optical design using the LIRIC procedure which shows an increase of the depth of focus of the
      contact lens when measured on an optical bench. It is hypothesized that a presbyopic patient
      wearing a soft contact lens of this design will experience an improvement in intermediate and
      near vision over that provided by their distance corrected single vision contact lenses,
      without significantly impacting their distance vision. The purpose of this feasibility study
      is the on-eye evaluation of the performance of the Clerio Vision designed and LIRIC modified
      soft contact lenses. Results from this study will guide future development of these potential
      products.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 6, 2018</start_date>
  <completion_date type="Actual">October 12, 2018</completion_date>
  <primary_completion_date type="Actual">August 27, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>This single center study is a device feasibility, two-arm, double-masked (participants and outcomes assessor), repeated measures, cross-sectional design. Each participant is tested with the four (4) study devices (i.e., contact lenses), one (1) test lens and three (3) control lenses, in randomized order. Participants are masked to each lens they wear.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>The Principal Investigator and Clinical Research Technicians, because they handle the contact lenses both in and out of their packaging, are not masked.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of Through-Focus High Contrast logMAR Visual Acuity for the Test Bifocal Contact Lens Versus that of the Control Bifocal Contact Lens, the Control Single Vision Contact Lens 1, and the Control Single Vision Contact Lens 2</measure>
    <time_frame>starting from visit 2 (after enrollment) and finishing with visit 3, the exit visit (up to 60 days after visit 2)</time_frame>
    <description>Visual acuity is measured under high contrast conditions (85% contrast relative to the chart background) at object testing distances of 5.3m, 2m, 1m, 67cm, 50cm and 40cm (&quot;through-focus&quot;), recorded in units of logMAR.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of Through-Focus Low Contrast logMAR Visual Acuity for the Test Bifocal Contact Lens Versus that of the Control Bifocal Contact Lens, the Control Single Vision Contact Lens 1, and the Control Single Vision Contact Lens 2</measure>
    <time_frame>starting from visit 2 (after enrollment) and finishing with visit 3, the exit visit (up to 60 days after visit 2)</time_frame>
    <description>Visual acuity is measured under low contrast conditions (10% contrast relative to the chart background) at object testing distances of 5.3m, 2m, 1m, 67cm, 50cm and 40cm (&quot;through-focus&quot;), recorded in units of logMAR.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Visual Quality for the Test Bifocal Contact Lens Versus that of the Control Bifocal Contact Lens, the Control Single Vision Contact Lens 1, and the Control Single Vision Contact Lens 2</measure>
    <time_frame>starting from visit 2 (after enrollment) and finishing with visit 3, the exit visit (up to 60 days after visit 2)</time_frame>
    <description>Visual quality is a subjective rating that a participant chooses using an analog rating chart ranging from 0 to 100. Participants are asked to look at the letters that they can read, not the ones that they can't, and rate how sharp those letters are, with 0 denoting &quot;unacceptable&quot; and 100 denoting &quot;excellent.&quot; They are asked to reduce their score if any halos, glare, or double vision are present.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of Fitting Performance for the Test Bifocal Contact Lens Versus that of the Control Bifocal Contact Lens, the Control Single Vision Contact Lens 1, and the Control Single Vision Contact Lens 2</measure>
    <time_frame>starting from visit 2 (after enrollment) and finishing with visit 3, the exit visit (up to 60 days after visit 2)</time_frame>
    <description>Fitting performance is measured by visual observation of the contact lens on a participant's eye using a slit lamp biomicroscope and ocular measurement reticle. The position of the lens edge relative to the corneal boundaries both immediately before and immediately after a blink is measured.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Presbyopia</condition>
  <arm_group>
    <arm_group_label>Test Device</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Within this arm the Clerio Vision LIRIC-modified Bifocal Contact Lens is administered.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Devices</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Within this arm the Johnson &amp; Johnson 1-Day Acuvue Moist Multifocal Contact Lens, Johnson &amp; Johnson 1-Day Acuvue Moist Contact Lens, and Clerio Vision Single Vision Contact Lens are administered.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Clerio Vision LIRIC-modified Bifocal Contact Lens</intervention_name>
    <description>Within this arm the investigational acofilcon B material bifocal contact lens, which has been modified with the laser and is the focus of the study, is tested. This lens is one of four (4) administered to each participant, tested on either visit 2 or 3 according to the randomization schedule, for a period of approximately 20 minutes.</description>
    <arm_group_label>Test Device</arm_group_label>
    <other_name>Clerio Vision Bifocal Contact Lens</other_name>
    <other_name>Clerio Vision Multifocal Contact Lens</other_name>
    <other_name>Laser-Induced Refractive Index Change (LIRIC) Bifocal Contact Lens</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Johnson &amp; Johnson 1-Day Acuvue Moist Multifocal Contact Lens</intervention_name>
    <description>Within this arm the control etafilcon A material bifocal contact lens, which is commercially available, is tested. This lens is one of four (4) administered to each participant, tested on either visit 2 or 3 according to the randomization schedule, for a period of approximately 20 minutes.</description>
    <arm_group_label>Control Devices</arm_group_label>
    <other_name>Commercially Available Multifocal Contact Lens</other_name>
    <other_name>Control Multifocal Contact Lens</other_name>
    <other_name>Etafilcon A</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Johnson &amp; Johnson 1-Day Acuvue Moist Contact Lens</intervention_name>
    <description>Within this arm the control etafilcon A material single vision contact lens, which is commercially available, is tested. This lens is one of four (4) administered to each participant, tested on either visit 2 or 3 according to the randomization schedule, for a period of approximately 20 minutes.</description>
    <arm_group_label>Control Devices</arm_group_label>
    <other_name>Commercially Available Single Vision Contact Lens</other_name>
    <other_name>Control Single Vision Contact Lens</other_name>
    <other_name>Etafilcon A</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Clerio Vision Single Vision Contact Lens</intervention_name>
    <description>Within this arm the control acofilcon B material single vision contact lens, the material of which is commercially available from Contamac Ltd, is tested. This lens is one of four (4) administered to each participant, tested on either visit 2 or 3 according to the randomization schedule, for a period of approximately 20 minutes.</description>
    <arm_group_label>Control Devices</arm_group_label>
    <other_name>Contamac 49 Single Vision Contact Lens</other_name>
    <other_name>Control Single Vision Contact Lens</other_name>
    <other_name>Acofilcon B</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Legal age (at least 21) on the date the Informed Consent Form (ICF) is signed and have
             the capacity to provide voluntary informed consent

          -  Able to read, understand and provide written informed consent on the Institutional
             Review Board (IRB)/Ethics Committee (EC) approved ICF and provide authorization as
             appropriate for local privacy regulations.

          -  Willing and able to comply with all study instructions/procedures.

          -  Best Distance Spherical Corrected Visual Acuity (BDSCVA) in at least one eye of 20/25
             (0.10 logMAR).

          -  Physiologically normal anterior segments not exhibiting clinically significant
             biomicroscopy findings.

          -  Previous experience with contact lenses.

          -  Distance spectacle spherical correction in at least one eye within +/- 5D of the study
             lens power (-3.00D).

          -  Habitual spectacle addition (at 40cm) of at least +1.00D.

          -  Refractive astigmatism less than -2.75D.

          -  Most recent complete eye examination was within the last 24 months of the date of
             study completion.

        Exclusion Criteria:

          -  Currently participating in any drug or device clinical investigation during the period
             of study participation.

          -  Active anterior segment ocular disease or using any ocular medication for anterior
             segment disease (e.g. conjunctivitis, dry-eye disease).

          -  Current or past condition that might have caused corneal distortion or anterior
             surface topography abnormalities (e.g. keratoconus, map-dot fingerprint or any other
             corneal dystrophies, corneal disease or trauma resulting in scarring, pterygium,
             pellucid marginal degeneration)

          -  Previous refractive corneal surgery (e.g., laser-assisted in situ keratomileusis
             (LASIK), photorefractive keratectomy (PRK), corneal transplant, Descemet's Stripping
             Endothelial Keratoplasty (DSEK) etc.).

          -  Considered by the Investigator to not be a suitable candidate for participation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michele Lagana, OD</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>Clerio Vision Research Clinic</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14607</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Ding L, Blackwell R, Kunzler JF, Knox WH. Large refractive index change in silicone-based and non-silicone-based hydrogel polymers induced by femtosecond laser micro-machining. Opt Express. 2006 Nov 27;14(24):11901-9.</citation>
    <PMID>19529613</PMID>
  </reference>
  <reference>
    <citation>Ding L, Knox WH, BÃ¼hren J, Nagy LJ, Huxlin KR. Intratissue refractive index shaping (IRIS) of the cornea and lens using a low-pulse-energy femtosecond laser oscillator. Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5332-9. doi: 10.1167/iovs.08-1921. Epub 2008 Jul 18.</citation>
    <PMID>18641284</PMID>
  </reference>
  <reference>
    <citation>Xu L, Knox WH, DeMagistris M, Wang N, Huxlin KR. Noninvasive intratissue refractive index shaping (IRIS) of the cornea with blue femtosecond laser light. Invest Ophthalmol Vis Sci. 2011 Oct 17;52(11):8148-55. doi: 10.1167/iovs.11-7323.</citation>
    <PMID>21931133</PMID>
  </reference>
  <reference>
    <citation>Savage DE, Brooks DR, DeMagistris M, Xu L, MacRae S, Ellis JD, Knox WH, Huxlin KR. First demonstration of ocular refractive change using blue-IRIS in live cats. Invest Ophthalmol Vis Sci. 2014 Jul 1;55(7):4603-12. doi: 10.1167/iovs.14-14373.</citation>
    <PMID>24985471</PMID>
  </reference>
  <reference>
    <citation>Wozniak KT, Elkins N, Brooks DR, Savage DE, MacRae S, Ellis JD, Knox WH, Huxlin KR. Contrasting cellular damage after Blue-IRIS and Femto-LASIK in cat cornea. Exp Eye Res. 2017 Dec;165:20-28. doi: 10.1016/j.exer.2017.08.018. Epub 2017 Aug 31.</citation>
    <PMID>28866013</PMID>
  </reference>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>August 27, 2018</study_first_submitted>
  <study_first_submitted_qc>August 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2018</study_first_posted>
  <disposition_first_submitted>April 8, 2019</disposition_first_submitted>
  <disposition_first_submitted_qc>April 12, 2019</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">April 19, 2019</disposition_first_posted>
  <last_update_submitted>April 12, 2019</last_update_submitted>
  <last_update_submitted_qc>April 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Refractive Errors</keyword>
  <keyword>Myopia</keyword>
  <keyword>Hyperopia</keyword>
  <keyword>Astigmatism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Presbyopia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted, but a results disposition has been submitted           -->
</clinical_study>

